Back to mobile site

Waldencast agrees to sell Obagi Medical to Bridgepoint for up to $460 million

June 1, 2026 6:59 AM EDT Send to a Friend
Waldencast plc (NASDAQ: WALD) announced it entered into a definitive agreement to sell its Obagi Medical dermatological skincare business to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login